Close Menu

How's this for belt-tightening? The Wall Street Journal reports that GlaxoSmithKline has announced it will "no longer use corporate funds for political contributions as part of an effort to improve openness in its business," according to the article. The company donated more than $585,000 in the US this year. (The company adopted this same policy in Europe in 2001.) No word, though, on whether that money will be redirected to R&D.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.